Putrescine is the major source of y-aminobutyric acid (GABA) in the rat adrenal gland. Diamine oxidase, and not monoamine oxidase, is essential for GABA formation from putrescine in the adrenal gland. Aminoguanidine, a diamine oxidase inhibitor, decreases the GABA concentration in the adrenal gland by more then 70 % after 4 h, and almost to zero in 24 h. Studies using [14C]putrescine confirm that [14C]GABA is the major metabolite of putrescine in the adrenal gland. Inhibition of GABA transaminase by aminooxyacetic acid does not change the GABA concentration in the adrenal gland, as compared with the brain, where the GABA concentration rises. With aminoguanidine, the turnover time of GABA originating from putrescine in the adrenal gland is 5.6 h, reflecting a slower rate of GABA metabolism compared with the brain. Since GABA in the adrenal gland is almost exclusively derived from putrescine, the role of GABA may relate to the role of putrescine as a growth factor and regulator of cell metabolism.
INTRODUCTION
Putrescine (1,4-diaminobutane) is a precursor of the polyamines spermidine and spermine, which are found throughout nature and are involved in numerous cellular regulatory processes (Heby, 1981; Grillo, 1985) . However, putrescine also is metabolized to y-aminobutyric acid (GABA) in mammalian organs under a variety of physiological and developmental conditions (Seiler et al., 1971; Kremzner et al., 1975; DeMello et al., 1976; Sobue & Nakajima, 1978; Sourkes & Missala, 1981; Fogel et al., 1982) .
The finding of non-neural GABA in a variety of tissues (Tanaka, 1985) has led to a search for its function outside the nervous system. Emphasis has focused on GABA in the pancreas (Gerber & Hare, 1979; Taniguchi et al., 1979; Vincent et al., 1983; Fung et al., 1985; Caron et al., 1987) and the female reproductive system (Martin del Rio, 1981; Apud et al., 1984; Murashima & Kato, 1986; Celotti et al., 1986) .
GABA is present in the adrenal gland (Martin del Rio & Caballero, 1980; Tanaka, 1985) , a complex organ with endocrine and neural functions. Biochemical studies have demonstrated the presence of GABA in adrenal chromaffin cells, where there is evidence for its role in modulating the release of catecholamines from the adrenal medulla (Kataoka et al., 1984) . Reports that the action of GABA in the adrenal chromaffin cell can be modulated by benzodiazepines (Bormann & Clapham, 1985; Kataoka et al., 1984) have wide implications for the role of GABA in the autonomic nervous system. The fact that GABA and polyamine metabolism is closely associated with nervous and endocrine tissues (Seiler, 1980) Preparation of tissue In all experiments the animals were killed by decapitation, and the adrenal glands and brain were dissected, and immediately placed in cold 0.9% NaCl, blotted, and weighed. The tissues were homogenized [1:15 (w/v) for adrenal gland; 1:5 (w/v) for brain] in ice-cold 0.4M-HCl04 with a motor-driven glass pestle. All tissue extracts were left on ice for at least 30 min, and then were centrifuged at 35 000 g for 10 min, in a Sorvall Superspeed RC-2 centrifuge. The pellet was discarded and the supernatant was stored at 4 'C.
Measurement of polyamines and GABA by h.p.l.c. The polyamines were dansylated and separated by h.p.l.c. on a C18 reverse-phase column (Waters Associates), and were quantified by fluorimetry by methods described by Caron et al. (1987) . GABA was measured on a h.p.l.c. cation-exchange Aminex A-9 column (BioRad, Richmond, CA, U.S.A.) and quantified by using o-phthaldialdehyde as described by Caron et al. (1987) . Standard solutions of putrescine, spermidine and spermine showed linearity with respect to the concentration. The sensitivity was 5-10 pmol, with less than 10% error.
RESULTS

Endogenous concentrations of polyamines and GABA in rat adrenal gland
The GABA concentration in the adrenal gland is about 4 times that of putrescine, whereas in the brain it is about 800 times that of putrescine (Table 1 ). The brain contains nearly equivalent concentrations of spermidine and spermine. In the adrenal gland, spermine content is more than 5 times that of spermidine. To assess whether GABA is localized to the cortex or medulla of the rat adrenal gland, the two regions were separated by careful dissection and examined histologically to verify the anatomy. The cortex and medulla of the rat adrenal gland contain 11.7 and 20.6 nmol of GABA/g wet wt. respectively.
GAD activity
The GAD activity in the rat adrenal gland is 2.1 + 0.4 ,umol/h per g wet wt., whereas in the whole rat brain it is 19.0 + 2.0,umol/h per g wet wt. Thus approximately a 10-fold greater GAD activity, and a 100-fold higher GABA concentration, are found in the rat brain as compared with the adrenal gland.
Glutamate decarboxylase (GAD) assay GAD (L-glutamate 1-carboxy-lyase, EC 4.1.1.15) activity was measured as described by Wu et al. (1973) Putrescine and y-aminobutyrate in adrenal gland The relative contribution of [14C] putrescine to the endogenous pool of GABA in the rat adrenal gland, i.e.
[14C]GABA c.p.m./nmol of GABA, is at least 104-fold greater than in the brain ( Table 2) .
Effects of diamine oxidase and monoamine oxidase inhibitors
Aminoguanidine sulphate (60 mg/kg) and pargyline hydrochloride (60 mg/kg), inhibitors of diamine oxidase (EC 1.4.3.6) and monoamine oxidase (EC 1.4.3.4) respectively, were administered in vivo to distinguish between the two possible pathways of GABA formation from putrescine. Aminoguanidine decreases GABA by 70 % in the adrenal gland, whereas pargyline does not change the GABA content 4 h after administration. Aminoguanidine, but not pargyline, given 4 h before [14C]putrescine injection, virtually eliminates the formation of [14C]GABA.
Turnover of GABA in the adrenal gland
The effect of aminoguanidine on GABA content in the adrenal gland was investigated in an effort to determine the turnover rate of GABA. The turnover rate is defined here as the time needed to decrease GABA to zero, assuming that it is synthesized and metabolized at a steady rate.
The rate of disappearance of GABA in the adrenal gland is plotted as a function of time after the administration of aminoguanidine (60 mg/kg) (Fig. 2) . Aminoguanidine depletes the endogenous GABA content of the adrenal gland to nearly zero in 24 h. Linearregression analysis shows that the concentration of GABA in the adrenal gland declines" at a rate of 4.3 nmol/h per g wet wt. Thus the turnover time for GABA is 5.6 h. Metabolism of GABA in the adrenal gland in vivo Amino-oxyacetic acid hemihydrochloride (25 mg/kg), an inhibitor of GABA transaminase (y-aminobutyrate: 2-oxyglutarate aminotransferase, EC 2.6.1.19), does not significantly change the GABA concentration in the adrenal gland (control, 24+10 nmol/g wet wt.) compared with 4 h after administration (23 + 10 nmol/g wet wt.).
DISCUSSION
Our studies show that GABA in the rat adrenal gland is derived mainly from putrescine, and not from glutamic acid. Putrescine in the adrenal gland is more readily converted via diamine oxidase into GABA, rather than into the polyamines spermidine and spermine. Since aminoguanidine, a diamine oxidase inhibitor, and not pargyline, a monoamine oxidase inhibitor, drastically decreases the GABA concentration in the adrenal gland, monoamine oxidase cannot play a major role in GABA formation from putrescine.
Using immunohistochemical staining, Kataoka et al. (1984) found that 40 % of bovine adrenal chromaffin Vol. 251 cells in culture stain positively for GAD, and 70 % for GABA transaminase. In light of the new evidence presented in our paper, the significance of GADcontaining cells must be modified and re-examined to include putrescine as a major contributor to GABA in the adrenal gland.
On the basis of our results, the catabolism of GABA in the adrenal gland is similar to that in the rat ovary and oviduct, where amino-oxyacetate does not increase GABA (Erdo et al., 1982; Martin del Rio & Lopez, 1983) . This is in contrast with the brain (Perry & Hansen, 1973; Bernasconi et al., 1982) and pancreas (Okada & Taniguchi, 1980; Caron et al., 1987) , where GABA is markedly increased after amino-oxyacetate administration.
Data from our studies of ['4C] putrescine injections show that the ['4C]GABA that is formed in the adrenal gland is not rapidly metabolized. However, in the brain,
[14C]putrescine is rapidly metabolized (Caron et al., 1987) . This adds further evidence that a different rate of GABA metabolism exists in the two organs.
The turnover time of GABA in the adrenal gland was found to be 5.6 h (Fig. 2) . This differs from the short turnover time of 1 h in the rodent brain (Caron et al., 1987) . Since aminoguanidine is used in our study, the turnover time reflects the majority of GABA originating from putrescine in the adrenal gland. Whether GADderived GABA has a different turnover time from putrescine-derived GABA is yet to be determined.
The strongest evidence for a functional role for GABA in the adrenal gland comes from studies done in the adrenal medulla, where a high uptake and release mechanism for GABA is found in the brain (Sangiah et al., 1974; Yamanaka et al., 1983; Kataoka et al., 1984; Bormann & Clapham, 1985) . GABA is known to cause the release of catecholamines from the adrenal medulla, similar to that of autonomic ganglia. This action can be affected by GABA antagonists, such as bicuculline and picrotoxin (Sangiah et al., 1974; Yamanaka et al., 1983) .
Further studies of GABA in the adrenal gland must take into consideration its formation from putrescine. In the adrenal gland, GABA is derived almost exclusively from putrescine, a growth factor. This suggests that GABA may play a role in the growth and metabolism of the adrenal gland.
